SCPH Insider Trading Activity and SEC Form 4 Filings
SCPH insider trading summary
No open-market insider purchases or sales of scPharmaceuticals Inc. (SCPH) have been reported on SEC Form 4 in the past 12 months.
Latest SCPH insider buys and sells
| Date | Insider | Role | Type | Value |
|---|---|---|---|---|
| Aug 13, 2024 | Orbimed Advisors LLC | 10% Owner | Buy | $87K (21,658 @ $4.00) |
| Aug 13, 2024 | Orbimed Advisors LLC | 10% Owner | Buy | $1.9M (478,342 @ $4.00) |
| Aug 13, 2024 | OrbiMed Genesis GP LLC | 10% Owner | Buy | $1.9M (478,342 @ $4.00) |
| Aug 13, 2024 | OrbiMed Capital GP VI LLC | 10% Owner | Buy | $1.9M (478,342 @ $4.00) |
| Aug 13, 2024 | OrbiMed Capital GP VI LLC | 10% Owner | Buy | $87K (21,658 @ $4.00) |
| Aug 13, 2024 | OrbiMed Genesis GP LLC | 10% Owner | Buy | $87K (21,658 @ $4.00) |
| Nov 25, 2022 | OrbiMed Capital GP VI LLC | 10% Owner | Buy | $4.0M (762,380 @ $5.25) |
| Nov 25, 2022 | Orbimed Advisors LLC | 10% Owner | Buy | $4.0M (762,380 @ $5.25) |
| Nov 25, 2022 | OrbiMed Genesis GP LLC | 10% Owner | Buy | $4.0M (762,380 @ $5.25) |
| Oct 10, 2022 | Scott M Rocklage | 10% Owner | Sell | $1.9M (456,413 @ $4.09) |
Source: SEC Form 4 filings. Open-market purchases (code P) and sales (code S) only; option exercises, grants and gifts are excluded.